Areas of Focus
- Development and translation of diagnostic and therapeutic technologies for live cells such as platelets and stem cells
- Mechanisms and interventions for the recurrence of malignant hematological diseases
- New methods for personalized diagnosis and treatment of hematological diseases based on artificial intelligence
Publications
- Overcoming Hypoxia by Multistage Nano Delivery System to Inhibit Mitochondrial Respiration for Photodynamic Therapy, Peipei Xu, 2019
- Tailoring the component of protein corona via simple chemistry, Peipei Xu, 2019
- Licochalcone A suppresses Sp1 expression with potential anti-myeloma activity, Peipei Xu, 2021
- Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphoma, Peipei Xu, 2017
- Ultrafast glucose-responsive, high loading capacity erythrocyte to self-regulate the release of insulin, Peipei Xu, 2018
- Platinum prodrug inhibiting tumor recurrence and metastasis by concurrent chemo radiotherapy, Peipei Xu, 2022
- Anti-Fas Antibody Conjugated Nanoparticles Enhancing the Antitumor Effect of Camptothecin by Activating the Fas−FasL Apoptotic Pathway, Peipei Xu, 2016
- Screening T‑Cell Activity via a Photodetachable DNA-Copolymer Nanocage and Its Therapeutic Application, Peipei Xu, 2022
- Overcoming the blood-brain barrier by using a multistage platelet delivery system to inhibit central nervous system lymphoma, Peipei Xu, 2022
- Ultrafast glucose-responsive, high loading capacity erythrocyte to self-regulate the release of insulin, Peipei Xu, 2018
- PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma, Peipei Xu, 2021
- Novel two-chain structure utilizing KIRS2/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r/r B-ALL, Peipei Xu, 2021
- Vincristine-Loaded Platelets Coated with Anti-CD41 MAbs: A New Proposal for the Treatment of Immune Thrombocytopenia, Peipei Xu, 2019
- Nitroxide-radicals-modified gold nanorods for in vivo CT/MRI-guided photothermal cancer therapy, Peipei Xu, 2018
- Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment, Peipei Xu, 2020
- Acetazolamide-Loaded pH-Responsive Nanoparticles Alleviating Tumor Acidosis to Enhance Chemotherapy Effects, Peipei Xu, 2019
- Gene signatures and prognostic values of m6A-related genes in multiple myeloma, Peipei Xu, 2021
- Identification of three immune molecular subtypes associated with immune profiles, immune checkpoints, and clinical outcome in multiple myeloma, Peipei Xu, 2021
- Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphoma, Peipei Xu, 2017
- Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors, Peipei Xu, 2017
- A centromere-associated gene score for rapid determination of risk in multiple myeloma, Peipei Xu, 2020
- Bortezomib activation of mTORC1 pathway mediated by NOX2-drived reactive oxygen species results in apoptosis in primary dorsal root ganglion neurons, Peipei Xu, 2021
- Pre-treatment red blood cell distribution width provides prognostic information in multiple myeloma, Peipei Xu, 2018
- PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma, Peipei Xu, 2020
- Expression of MAGE-C1/CT7 provides prognostic information in multiple myeloma, Peipei Xu, 2017
- MiR-181a enhances drug sensitivity of mixed lineage leukemia- rearranged acute myeloid leukemia by increasing poly(ADP-ribose) polymerase1 acetylation, Peipei Xu, 2021
- Effects of digoxin on cell cycle, apoptosis and NF-kappa B pathway in Burkitt's lymphoma cells and animal model, Peipei Xu, 2017
- TP53 mutation predicts the poor prognosis of non-Hodgkin lymphomas: Evidence from a meta-analysis, Peipei Xu, 2017
- Anti-CD22-conjugated CdTe QDs co-loaded with doxorubicin and gambogic acid: a novel platform for lymphoma treatment, Peipei Xu, 2017
- Correlation of miR- 181a and three HOXA genes as useful biomarkers in acute myeloid leukemia, Peipei Xu, 2020
- Wogonin Inhibits Growth of Mantle Cell Lymphoma Cells, through Nuclear Factor-κB Signaling Pathway, Peipei Xu, 2018
- Development of follicular lymphoma after treatment of diffuse large B- cell lymphoma: two case reports with review of literature, Peipei Xu, 2018
- Successful management of a complicated clinical crisis: A patient with left- sided endocarditis and secondary hemophagocytic lymphohistiocytosis: a rare case report and literature review, Peipei Xu, 2017
- Doxorubicin-Loaded CuS Nanoparticles Conjugated with GFLG: A Novel Drug Delivery System for Lymphoma Treatment, Peipei Xu, 2019
- Higher single dose of bortezomib plus thalidomide and dexamethasone is a promising therapy for newly diagnosed multiple myeloma, Peipei Xu, 2019
- Refractory multiple myeloma with extramedullary plasmacytoma of the spleen and suspicious teratoma: a rare case report and literature review, Peipei Xu, 2021
Awards
- Excellent Conference Presentation, Second Prize (2017): Construction and Anti-Tumor Effect of CD22-Platelet-DOX Targeted Drug Delivery System
- Best Paper Award (2019): National Thrombosis and Hemostasis Academic Conference
- First Prize (2017): Research on Platelet-Loaded Chemotherapy Drugs for the Treatment of Malignant Tumors, Jiangsu Oncology Medical Science and Technology Award
- First Prize (2019): Application of Immune Recognition-Based Targeted Platelet Drug Delivery System in Hematological Tumors, Provincial and Ministerial Best Paper Award
- First Prize (2020): Construction and Implementation of Personalized Diagnosis and Treatment Strategy System for Malignant Hematological Diseases Based on Artificial Intelligence, Provincial and Ministerial Medical New Technology Introduction Award
- Third Prize (2017): Basic and Clinical Translational Research on Cardiac Steroids and Nanotechnology for the Treatment of Lymphatic System Tumors, Nanjing Science and Technology Progress Award
